血液浄化装置:医療機器パイプライン分析

◆英語タイトル:Blood Purification Equipment - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0159
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:202
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥424,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥848,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,272,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Blood Purification Equipment – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Blood Purification Equipment – Medical Devices Pipeline Assessment, 2019″ provides an overview of Blood Purification Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Blood Purification Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Blood Purification Equipment under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Blood Purification Equipment and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Blood Purification Equipment under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 6
1.2 List of Figures 9
2 Introduction 10
2.1 Blood Purification Equipment Overview 10
3 Products under Development 11
3.1 Blood Purification Equipment – Pipeline Products by Stage of Development 11
3.2 Blood Purification Equipment – Pipeline Products by Territory 12
3.3 Blood Purification Equipment – Pipeline Products by Regulatory Path 14
3.4 Blood Purification Equipment – Pipeline Products by Estimated Approval Date 15
3.5 Blood Purification Equipment – Ongoing Clinical Trials 16
4 Blood Purification Equipment – Pipeline Products under Development by Companies 17
4.1 Blood Purification Equipment Companies – Pipeline Products by Stage of Development 17
4.2 Blood Purification Equipment – Pipeline Products by Stage of Development 18
5 Blood Purification Equipment Companies and Product Overview 20
5.1 Accel Diagnostics LLC Company Overview 20
5.1.1 Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 20
5.2 Aethlon Medical Inc Company Overview 21
5.2.1 Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Asahi Kasei Medical Co Ltd Company Overview 25
5.3.1 Asahi Kasei Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 25
5.4 Boston Children’s Hospital Company Overview 26
5.4.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 26
5.5 Cerus Corp Company Overview 27
5.5.1 Cerus Corp Pipeline Products & Ongoing Clinical Trials Overview 27
5.6 Chemofilter Inc (Inactive) Company Overview 34
5.6.1 Chemofilter Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 Cook Regentec LLC Company Overview 36
5.7.1 Cook Regentec LLC Pipeline Products & Ongoing Clinical Trials Overview 36
5.8 CytoSorbents Corp Company Overview 39
5.8.1 CytoSorbents Corp Pipeline Products & Ongoing Clinical Trials Overview 39
5.9 Delcath Systems Inc Company Overview 54
5.9.1 Delcath Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 54
5.10 EBO2 Inc Company Overview 59
5.10.1 EBO2 Inc Pipeline Products & Ongoing Clinical Trials Overview 59
5.11 Ex Vivo Dynamics Inc Company Overview 60
5.11.1 Ex Vivo Dynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.12 Good SIRS Company Overview 61
5.12.1 Good SIRS Pipeline Products & Ongoing Clinical Trials Overview 61
5.13 HemoTune AG Company Overview 62
5.13.1 HemoTune AG Pipeline Products & Ongoing Clinical Trials Overview 62
5.14 Immunicom Inc Company Overview 63
5.14.1 Immunicom Inc Pipeline Products & Ongoing Clinical Trials Overview 63
5.15 McGowan Institute for Regenerative Medicine Company Overview 68
5.15.1 McGowan Institute for Regenerative Medicine Pipeline Products & Ongoing Clinical Trials Overview 68
5.16 MediSieve Ltd Company Overview 69
5.16.1 MediSieve Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
5.17 Nipro Corp Company Overview 73
5.17.1 Nipro Corp Pipeline Products & Ongoing Clinical Trials Overview 73
5.18 Nonwovens Innovation & Research Institute Ltd Company Overview 74
5.18.1 Nonwovens Innovation & Research Institute Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
5.19 NxStage Medical Inc Company Overview 75
5.19.1 NxStage Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 75
5.20 Opsonix Inc Company Overview 76
5.20.1 Opsonix Inc Pipeline Products & Ongoing Clinical Trials Overview 76
5.21 Path Ex Inc Company Overview 77
5.21.1 Path Ex Inc Pipeline Products & Ongoing Clinical Trials Overview 77
5.22 ProSorp BioTech Inc Company Overview 78
5.22.1 ProSorp BioTech Inc Pipeline Products & Ongoing Clinical Trials Overview 78
5.23 Spectral Medical Inc Company Overview 79
5.23.1 Spectral Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 79
5.24 Toray Medical Co Ltd Company Overview 82
5.24.1 Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
5.25 Zata Pharmaceuticals Inc Company Overview 83
5.25.1 Zata Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 83
6 Blood Purification Equipment- Recent Developments 86
6.1 Nov 25, 2019: CytoSorbents changes Contract Research Organizations and temporarily pauses enrollment in REFRESH 2-AKI Study 86
6.2 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 86
6.3 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 88
6.4 Nov 06, 2019: Dr. Eric Mortensen to leave CytoSorbents at year end 89
6.5 Nov 05, 2019: CytoSorbents reports third quarter 2019 financial results 90
7 Appendix 199
7.1 Methodology 199
7.2 About GlobalData 202
7.3 Contact Us 202
7.4 Disclaimer 202

List of Tables
Table 1: Blood Purification Equipment - Pipeline Products by Stage of Development
Table 2: Blood Purification Equipment - Pipeline Products by Territory
Table 3: Blood Purification Equipment - Pipeline Products by Regulatory Path
Table 4: Blood Purification Equipment - Pipeline Products by Estimated Approval Date
Table 5: Blood Purification Equipment - Ongoing Clinical Trials
Table 6: Blood Purification Equipment Companies - Pipeline Products by Stage of Development
Table 7: Blood Purification Equipment - Pipeline Products by Stage of Development
Table 8: Accel Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 9: mPharesis - Product Status
Table 10: mPharesis - Product Description
Table 11: Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: ASEPSYS Device - Product Status
Table 13: ASEPSYS Device - Product Description
Table 14: Hemopurifier - Product Status
Table 15: Hemopurifier - Product Description
Table 16: Aethlon Medical Inc - Ongoing Clinical Trials Overview
Table 17: Hemopurifier - An Early Feasibility Study of Hemopurifier in Patients with Head and Neck Cancer
Table 18: Hemopurifier - Plasma Exosome Concentration in Cancer Patients Undergoing Treatment
Table 19: Hemopurifier - Sepsis-related Virus Study of Aethlon Hemopurifier
Table 20: Asahi Kasei Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Mysorba - Product Status
Table 22: Mysorba - Product Description
Table 23: Boston Children's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Blood Filtration Device - Product Status
Table 25: Blood Filtration Device - Product Description
Table 26: Cerus Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 27: INTERCEPT Blood System - Platelets - Product Status
Table 28: INTERCEPT Blood System - Platelets - Product Description
Table 29: INTERCEPT Blood System - Red Blood Cells - Product Status
Table 30: INTERCEPT Blood System - Red Blood Cells - Product Description
Table 31: INTERCEPT Blood System - Zika Virus - Product Status
Table 32: INTERCEPT Blood System - Zika Virus - Product Description
Table 33: Cerus Corp - Ongoing Clinical Trials Overview
Table 34: INTERCEPT Blood System - Platelets - A Randomized, Multi-center, Multi-Stage, Controlled, In Vivo Study to Assess the Recovery and Survival of Radiolabeled Autologous INTERCEPT Apheresis Platelet Components Suspended in 100% Plasma Stored for up to 7 Days
Table 35: INTERCEPT Blood System - Red Blood Cells - A Randomized, Double-blinded, Controlled, Parallel Group, Non-inferiority, Phase III Study to Evaluate the Efficacy and Safety of the INTERCEPT Blood System for Red Blood Cells in Patients Undergoing Complex Cardiac Surgery Procedures
Table 36: INTERCEPT Blood System - Red Blood Cells - Measurement of the Recovery and Lifespan of Red Blood Cells from Pathogen-reduced, Stored Blood Units Using Cellular Biotinylation
Table 37: INTERCEPT Blood System - Red Blood Cells - Randomized, Double-blind, Controlled, Parallel Group Study with the INTERCEPT Blood System for RBCs in Regions at Potential Risk for Zika Virus Transfusion-transmitted Infections and Treatment Use Open-label Extension Study
Table 38: Chemofilter Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 39: ChemoFilter Device - Product Status
Table 40: ChemoFilter Device - Product Description
Table 41: Next-Generation ChemoFilter Device - Product Status
Table 42: Next-Generation ChemoFilter Device - Product Description
Table 43: Cook Regentec LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 44: HemaTrate - Critical Limb Ischemia - Product Status
Table 45: HemaTrate - Critical Limb Ischemia - Product Description
Table 46: Cook Regentec LLC - Ongoing Clinical Trials Overview
Table 47: HemaTrate - Critical Limb Ischemia - Clinical Study of the Use of an Autologous Blood Filtration Device in the Treatment of Critical Limb Ischemia
Table 48: CytoSorbents Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 49: BetaSorb - Product Status
Table 50: BetaSorb - Product Description
Table 51: ContrastSorb - Product Status
Table 52: ContrastSorb - Product Description
Table 53: CST 301 - Product Status
Table 54: CST 301 - Product Description
Table 55: CytoSorb - Product Status
Table 56: CytoSorb - Product Description
Table 57: CytoSorb-XL - Product Status
Table 58: CytoSorb-XL - Product Description
Table 59: DrugSorb - Product Status
Table 60: DrugSorb - Product Description
Table 61: HemoDefend - Product Status
Table 62: HemoDefend - Product Description

List of Figures
Figure 1: Blood Purification Equipment - Pipeline Products by Stage of Development
Figure 2: Blood Purification Equipment - Pipeline Products by Territory
Figure 3: Blood Purification Equipment - Pipeline Products by Regulatory Path
Figure 4: Blood Purification Equipment - Pipeline Products by Estimated Approval Date
Figure 5: Blood Purification Equipment - Ongoing Clinical Trials

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[血液浄化装置:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆